124 related articles for article (PubMed ID: 6167819)
21. Hemodynamic assessment of prenalterol: a cardioselective beta agonist in patients with imparied left ventricular function.
Klein W; Brandt D; Maurer E
Clin Cardiol; 1981; 4(6):325-9. PubMed ID: 6120057
[TBL] [Abstract][Full Text] [Related]
22. The effects of intravenous prenalterol on ventricular performance, as assessed by radionuclide ventriculography, in patients with ischaemic heart disease.
Muir AL; Hannan WJ; Dewhurst NG; Slessor IM
Br J Clin Pharmacol; 1981 Oct; 12(4):475-80. PubMed ID: 7295483
[TBL] [Abstract][Full Text] [Related]
23. Prenalterol, an oral beta-1 adrenoceptor agonist, in the treatment of chronic heart failure.
Sharpe DN; Coxon R
Eur J Clin Pharmacol; 1983; 25(4):539-45. PubMed ID: 6653650
[TBL] [Abstract][Full Text] [Related]
24. The immediate haemodynamic and electrophysiological response to prenalterol during fixed rate pacing in patients with chronic ischaemic heart disease.
Sire S; Amlie JP; Simonsen S
Acta Pharmacol Toxicol (Copenh); 1986 Jan; 58(1):43-8. PubMed ID: 3953293
[TBL] [Abstract][Full Text] [Related]
25. Dose-response relationship in normal subjects of prenalterol, a beta-adrenergic agonist with positive inotropic and resistance lowering effects.
Rasmussen S; Høilund-Carlsen PF; Hesse B; Hartling OJ; Fabricius J; Dige-Petersen H; Giese J
Eur J Clin Pharmacol; 1984; 27(5):539-43. PubMed ID: 6151507
[TBL] [Abstract][Full Text] [Related]
26. Relative inotropic and chronotropic activity of beta-adrenoceptor stimulants in anaesthetised, areflexic dogs.
Engel B; Einstein R; Goodman AH
Eur J Pharmacol; 1983 Jan; 86(3-4):461-6. PubMed ID: 6131828
[TBL] [Abstract][Full Text] [Related]
27. Haemodynamic effects of dobutamine in patients with coronary artery disease.
Magnani B; Ambrosioni E; Branzi A; Picchio F; Capitanucci P
J Int Med Res; 1977; 5(1):10-7. PubMed ID: 838109
[TBL] [Abstract][Full Text] [Related]
28. Effects of inotropic agents on arterial resistance and venous compliance in anesthetized dogs.
Ogilvie RI
Can J Physiol Pharmacol; 1982 Jul; 60(7):968-76. PubMed ID: 7127215
[TBL] [Abstract][Full Text] [Related]
29. Prenalterol: a partial beta 1-adrenoceptor agonist or a beta-blocker with intrinsic activity?
Wirtzfeld A; Klein G; Bibra HV; Sauer E
Int J Clin Pharmacol Ther Toxicol; 1985 Jan; 23(1):20-7. PubMed ID: 2859252
[TBL] [Abstract][Full Text] [Related]
30. Comparative hemodynamic effects of inotropic and vasodilator drugs in severe heart failure.
Mikulic E; Cohn JN; Franciosa JA
Circulation; 1977 Oct; 56(4 Pt 1):528-33. PubMed ID: 902377
[TBL] [Abstract][Full Text] [Related]
31. Cardio-selective beta adrenergic stimulation with prenalterol in the conscious dog.
Manders WT; Vatner SF; Braunwald E
J Pharmacol Exp Ther; 1980 Oct; 215(1):266-70. PubMed ID: 6109017
[TBL] [Abstract][Full Text] [Related]
32. [Comparison of the hemodynamic effects induced by dobutamine, isoproterenol and dopamine in patients with coronary artery disease (author's transl)].
Ambrosioni E; Maresta A; Magnani B
G Ital Cardiol; 1979; 9(7):708-14. PubMed ID: 540702
[TBL] [Abstract][Full Text] [Related]
33. Hemodynamic actions of prenalterol in severe congestive heart failure due to chronic coronary disease.
Awan NA; Needham KE; Evenson MK; Win A; Mason DT
Am Heart J; 1981 Feb; 101(2):158-61. PubMed ID: 7468416
[TBL] [Abstract][Full Text] [Related]
34. Comparative hemodynamic effects of intravenous dobutamine and MDL-17,043, a new cardioactive drug, in severe congestive heart failure.
Amin DK; Shah PK; Shellock FG; Hulse S; Brandon G; Spangenberg R; Swan HJ
Am Heart J; 1985 Jan; 109(1):91-8. PubMed ID: 3155585
[TBL] [Abstract][Full Text] [Related]
35. Intravenous and oral prenalterol in congestive heart failure. Effects on systemic and coronary hemodynamics and myocardial catecholamine balance.
Wahr DW; Swedberg K; Rabbino M; Hoyle MJ; Curran D; Parmley WW; Chatterjee K
Am J Med; 1984 Jun; 76(6):999-1005. PubMed ID: 6731471
[TBL] [Abstract][Full Text] [Related]
36. [Effects of Prenalterol on left ventricular function of coronary patients].
Javernaro A; Bolognesi R; Giacometti P; Potenza D; Cortesi G; Cucchini F
Acta Biomed Ateneo Parmense; 1983; 54(1):17-8. PubMed ID: 6134412
[TBL] [Abstract][Full Text] [Related]
37. Hemodynamic effects of a new inotropic compound, PST-2744, in dogs with chronic ischemic heart failure.
Adamson PB; Vanoli E; Mattera GG; Germany R; Gagnol JP; Carminati P; Schwartz PJ
J Cardiovasc Pharmacol; 2003 Aug; 42(2):169-73. PubMed ID: 12883318
[TBL] [Abstract][Full Text] [Related]
38. [Catecholamines in the therapy of chronic cardiac insufficiency].
Brandt D; Klein W
Wien Med Wochenschr; 1982 Oct; 132(19):450-6. PubMed ID: 6294999
[No Abstract] [Full Text] [Related]
39. Hemodynamic and cardiometabolic effects of prenalterol in patients with gram negative septic shock.
Reiz S; Friedman A
Acta Anaesthesiol Scand; 1980; 24(1):5-10. PubMed ID: 7376804
[TBL] [Abstract][Full Text] [Related]
40. Effects of inotropic and chronotropic stimuli on acute myocardial ischemic injury. I. Studies with dobutamine in the anesthetized dog.
Rude RE; Izquierdo C; Buja LM; Willerson JT
Circulation; 1982 Jun; 65(7):1321-8. PubMed ID: 6804112
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
